Sunday, May 9, 2010

Filled Under:

First 4-phasic OCP approved

This OCP contains the progestin dienogest and the bioidentical synthetic estrogen estradiol valerate. It offers 4 progestin/estrogen dosage to be taken during each 28 day cycle. The failure rate is similar to other hormonal OCP. The side effects also are very similar  with headaches and menstrual irregularities being most common.
The birth control pill celebrates its 50 years on the 9th of this month.


Post a Comment